250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Medical Device VC (Venture Capital) Funds in United States in October 2023

A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in United states. We rank investors based on the number of investments they made in Medical device companies from United states. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in United States in October 2023

Investor Medical Device United States investments
Innova Memphis 71
Broadview Ventures 20
Portfolia 18
Connecticut Innovations 17
CincyTech 17
HealthTech Capital 17
MB Venture Partners 16
North Coast Ventures 16
Boston Harbor Angels 15
Oxford Finance LLC 15
Texas HALO Fund 15
Maine Angels 14
Good Growth Capital 14
Wavemaker 360 14
Wisconsin Investment Partners 13
TEDCO 13
Arboretum Ventures 13
Horizon Technology Finance 13
Ben Franklin Technology Partners of Southeastern Pennsylvania 13
Oxford Bioscience Partners 13
U.S. Venture Partners 13
Khosla Ventures 12
Catalyst Health Ventures 12
Canaan Partners 12
Catalyst Health Ventures 12
Sand Hill Angels 12
Versant Ventures 12
Tech Coast Angels 11
Houston Angel Network 11
Morgenthaler Ventures 11
Radius Ventures 11
Kleiner Perkins 11
Split Rock Partners 11
Shangbay Capital 10
DeNovo Ventures 10
Third Rock Ventures 10
Gaingels 10
St. Louis Arch Angels 10
Life Science Angels 10
Three Arch Partners 10
Virginia Venture Partners 10
Silicon Valley Bank 9
Mayo Clinic 9
Monte Carlo Capital 9
Hatteras Venture Partners 9
Boutique Venture Partners 9
Golden Seeds 9
Cherrystone Angel Group 9
New Enterprise Associates 9
Green Park & Golf Ventures 9

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Innova Memphis
VC Fund · Memphis, Tennessee, United States · 5 investments in the past 12 months

Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.

Show more...

Investment focus

  • Health Care, Medical, Medical Device
  • Seed, Pre-Seed, Convertible Note
  • United States, Argentina, United Kingdom

Portfolio highlights

  • Isomark Health — Isomark Health is a patented AI-based, real-time and 100% green breath technology that detects and prevents bacterial and viral infections.
  • Rantizo — Rantizo provides drone spraying systems and support services for custom applicators, agribusinesses and contractors. Elevating precision ag.
  • Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
Show more investments...

Broadview Ventures
VC Fund · Boston, Massachusetts, United States · 2 investments in the past 12 months

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Debt Financing
  • United States, Israel, Denmark

Portfolio highlights

  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Show more investments...

Portfolia
VC Fund · San Mateo, California, United States · 17 investments in the past 12 months

Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact

Show more...

Investment focus

  • Health Care, Software, Biotechnology
  • Seed, Series A, Series B
  • United States, Canada, Argentina

Portfolio highlights

  • Attn: Grace — Attn: Grace is a sustainable wellness brand designed for women. Starting with bladder leakage, they're creating thoughtful, more sustainable solutions for life’s inconvenient truths, one challenge at a time.
  • Prime Roots — Prime Roots is on a mission to provide a better cut of meat for every type of eater. Rooted in koji, Prime Roots is able to replicate the taste and texture of meat without any of the environmental costs of animal proteins.
  • Carbice Corporation — Carbice is the first no-compromise thermal interface material. It achieves all the advantages of both solid and liquid thermal interface materials without any of the pitfalls.
Show more investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 9 investments in the past 12 months

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Health Care, Biotechnology, Software
  • Series A, Seed, Funding Round
  • United States, Israel, Canada

Portfolio highlights

  • OOVA — OOVA is a fertility diagnostic company that spun out from Mount Sinai Hospital in New York City. Using patent pending biochemistry and artificial intelligence, OOVA learns a woman’s fertility profile by accurately measuring key hormones over time through daily urine samples. By monitoring this critical balance of hormones, OOVA can help a woman getpregnant, identify reasons she is having trouble getting pregnant, and even expose reproductive health issues like PCOS.
  • Raise Green — Raise Green is the climate tech marketplace for local impact investing licensed with the SEC and FINRA to sell private securities.
  • Driver Technologies — Turn your phone into a dash cam.
Show more investments...

CincyTech
VC Fund · Cincinnati, Ohio, United States · 3 investments in the past 12 months

CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed, Series A, Series B
  • United States

Portfolio highlights

  • Amify — We help brands selling on Amazon maximize sales and profitability by providing complete strategy, management and operational services.
  • Tembo — CoreDB provides a fully-managed, secure, scalable Postgres cluster with access to an ecosystem of extensions, expanding the capabilities of your database.
  • Voxel — Voxel utilizes advanced mathematics and artificial intelligence to rapidly generate functionally graded meta-materials for high performance applications through additive manufacturing. We provides performance leaps in the defence, automotive, aerospace, medical, industrial, and other demanding areas and unlock new capabilities for our customers.
Show more investments...

HealthTech Capital
VC Fund · Los Altos Hills, California, United States · 1 investment in the past 12 months

Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups

Show more...

Investment focus

  • Health Care, Medical Device, Medical
  • Seed, Series A, Convertible Note
  • United States

Portfolio highlights

  • Agile Therapeutics — Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name toAgile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.
  • GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
  • Wavely Diagnostics — Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
Show more investments...

MB Venture Partners
VC Fund · Memphis, Tennessee, United States

MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases

Show more...

Investment focus

  • Health Care, Medical, Medical Device
  • Seed, Series B, Series C
  • United States, Israel

Portfolio highlights

  • Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
  • SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
  • Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Show more investments...

North Coast Ventures
VC Fund · Cleveland, Ohio, United States · 4 investments in the past 12 months

North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.

Show more...

Investment focus

  • Health Care, Software, Medical Device
  • Series A, Seed, Funding Round
  • United States

Portfolio highlights

  • UnifyWork — UnifyWork's skills-based matching technology creates a faster way for employers to hire qualified talent, and helps job seekers find job opportunities meeting their skills and interests.
  • Bloomfilter — Bloomfilter is a developer of an enterprise software planning application. Bloomfilter helps software executives and leaders illuminate the path to software project success through our platform.
  • Vytalize Health — Vytalize Health is an all-in-one solution for independent primary care physicians participating in value-based care with Medicare. Vytalize integrates with physicians through people, technology, and unique value-based arrangements that result in better patient outcomes and better optimized care delivery.As of 2021, the company has 600+ PCPs,65K Medicare patients, and $1B in medical spending.
Show more investments...

Boston Harbor Angels
VC Fund · Boston, Massachusetts, United States

Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical Device
  • Angel, Seed, Series A
  • United States, Canada, India

Portfolio highlights

  • Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
  • Xeno Biosciences — Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show more investments...

Oxford Finance LLC
VC Fund · Alexandria, Virginia, United States · 3 investments in the past 12 months

Providing Flexible and Creative Financial Solutions to Life Sciences and Healthcare Services Companies.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Debt Financing, Post-IPO Debt, Series B
  • United States, Canada, United Kingdom

Portfolio highlights

  • Renibus Therapeutics — Renibus Therapeutics operates in the healthcare industry focusing on the pharmaceutical business. The company was incorporated in 2015 and is based in Lantana, Texas.
  • ALX Oncology — ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company.The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University.This discovery involves soluble versions of signal regulatory protein-α (SIRPα) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPα.1.
  • Pearl Street Dental Management — Pearl Street Dental Management supports non-clinical operations. They provide centralized services such as human resources, payroll, accounting, bookkeeping, finance, lending, facilities management, and information technology services. They address inquiries through online applications, phone calls, and emails.
Show more investments...

Texas HALO Fund
VC Fund · Houston, Texas, United States

Early Stage Venture Investments

Show more...

Investment focus

  • Health Care, Medical Device, Software
  • Seed, Convertible Note, Series A
  • United States, Canada, Hungary

Portfolio highlights

  • Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
  • Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
  • Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Show more investments...

Maine Angels
VC Fund · Portland, Maine, United States

Maine Angels they make investments with entrepreneurs with an emphasis on businesses.

Show more...

Investment focus

  • Health Care, Software, Biotechnology
  • Seed, Funding Round, Series A
  • United States

Portfolio highlights

  • HighByte — HighByte is an industrial software development company in Portland, Maine building solutions that address the data architecture and security challenges created by Industry 4.0.
  • TOP the organic project — 100% Organic Cotton Period Care. Organic Tampons, Pads, First Period Kit & Bulk Period Products. Women-owned, eco-friendly, plant-based and sustainable. With every subscription, TOP gives back to women in need.
  • Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
Show more investments...

Good Growth Capital
VC Fund · Charleston, South Carolina, United States · 11 investments in the past 12 months

Good Growth Capital specializes in finding, cultivating, and assessing complex science and deep-tech start-ups. GGC invests in seed-stage and Series A deals through the General Fund family and in pre-seed and seed-stage companies through the Infinite Corridor Fund, which primarily targets MIT-affiliated and transformative science start-ups. GGC ismajority women- and minority-owned and is uniquely positioned geographically in both the Southeast and New England.

Show more...

Investment focus

  • Health Care, Information Technology, Software
  • Seed, Convertible Note, Series A
  • United States, France, Israel

Portfolio highlights

  • Pryon — Pryon is the leading AI-as-a-Service platform for content and knowledge management. Pryon closes knowledge gaps, improving employee productivity, and enhancing customer experiences. Companies such as Georgia Pacific use Pryon to improve health and safety outcomes, eliminate compliance incidents, improve employee onboarding, and upgrade all aspectsof customer service and support.
  • VenoStent — VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.
  • Lemurian Labs — Lemurian Labs develops disruptive, highly parallel, ultra low-power inner-product architecture to make deep learning and computer vision applications on the edge, sustainable, resulting in higher inference throughput, a reduction in energy consumed and a decrease in heat generated from chip processing
Show more investments...

Wavemaker 360
VC Fund · Pasadena, California, United States · 6 investments in the past 12 months

Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.

Show more...

Investment focus

  • Health Care, Medical, Medical Device
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Canada

Portfolio highlights

  • 32Co — 32Co is a medical technology platform that helps general dentists deliver clear aligner orthodontics to their patients.
  • Essenvia — Rapidly submit eSTAR, EUMDR and IVDR applications, eliminate errors and accelerate approvals with the only regulatory submission platform made for MedTech
  • Gradient Health — One of the biggest barriers to accelerating AI development is access to large datasets of labeled pathologies.
Show more investments...

Wisconsin Investment Partners
VC Fund · Madison, Wisconsin, United States · 1 investment in the past 12 months

Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • United States, Canada, United Kingdom

Portfolio highlights

  • Sequoir — Sequoir is a financial technology firm providing blockchain trading and custody APIs to power banks, credit unions, fintech, and the Web 3.0.
  • Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
  • Nurse Disrupted — A virtual nursing program that retains nurses & improves hospital finances. Live in 4 weeks. Engaged, happier nurses in days.
Show more investments...

TEDCO
VC Fund · Columbia, Maryland, United States · 11 investments in the past 12 months

TEDCO was created by the Maryland State Legislature in 1998 to facilitate the transfer and commercialization of technology from Maryland’s research universities and federal labs into the marketplace and to assist in the creation and growth of technology-based businesses in all regions of the State. TEDCO is an independent organization thatstrives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. In Maryland and beyond, TEDCO is a resource of mentoring, funding and networking for entrepreneurs and start-ups that need guidance as they bring innovative concepts to market. TEDCO is more than an early stage funding resource. It is the hub of Maryland’s entrepreneurial network where startups find mentors, organizational assistance, facilities for daily operations, and a roadmap for success.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed, Pre-Seed, Series A
  • United States

Portfolio highlights

  • Hopr — Hopr recognizes the increasing relevance of cybersecurity in today's global digital society. Hopr objective is to assist organizations in protecting their digital operations and data by rethinking old challenges and then developing innovative cybersecurity solutions to tackle them.
  • Fem Equity — Fem Equity is a work platform that develops real-time solutions for women and underrepresented professionals experiencing salary or professional inequalities.
  • N5 Sensors — Sensors and solutions for protecting lives and infrastructure from environmental hazards.
Show more investments...

Arboretum Ventures
VC Fund · Ann Arbor, Michigan, United States · 2 investments in the past 12 months

For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Canada

Portfolio highlights

  • BrightSpec — LabBrightSpec addresses high-value, time-sensitive analytical chemistry challenges that are not well addressed by other spectroscopy techniques and instruments. It provides innovative laboratory services in order to deliver immediate results to potential customers of our instrumentation products. They are based in Charlottesville, Virginia,about two hours from Washington, DC. The BrightSpec Fourier transform molecular rotational resonance (FT-MRR) product platform is based on technology developed at the University of Virginia by Brooks Pate and his team, several of whom now work at BrightSpec. They offer FT-MRR product configurations for analytical chemistry and gas sensing in manufacturing process control, quality control, environmental monitoring, and formulation research.
  • Boomerang Medical — Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
  • Enumera Molecular — Enumera Molecular is a life science tools company headquartered in Ann Arbor, MI, developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests. It helps in transforming the field of clinical molecular testing into a simpler, more actionable tool for physicians to benefit patient care.
Show more investments...

Horizon Technology Finance
VC Fund · Farmington, Connecticut, United States · 5 investments in the past 12 months

Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Debt Financing, Post-IPO Debt, Funding Round
  • United States, Canada, India

Portfolio highlights

  • Unagi Scooters — Unagi is an electric scooter startup that aims to liberate people from the tyranny of transportation frustrations—the costs, inconveniences, the carbon emissions. So we built the ideal personal liberation device.
  • Evelo Biosciences — Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. Monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. These new medicines are broadlyapplicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. Monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. By finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, Evelo can improve the speed, cost and success of drug discovery and development. Evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. Evelo Biosciences was conceived and created within VentureLabs®, Flagship Pioneering’s institutional innovation foundry, and launched by Flagship in 2015.
  • Slingshot Aerospace — Slingshot Aerospace applies advanced analytics, machine learning, and collaborative tools to data from earth and space, providing clarity in complex environments.
Show more investments...

Ben Franklin Technology Partners of Southeastern Pennsylvania
VC Fund · Philadelphia, Pennsylvania, United States · 4 investments in the past 12 months

We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

Show more...

Investment focus

  • Health Care, Software, Information Technology
  • Seed, Grant, Debt Financing
  • United States

Portfolio highlights

  • Yellowdig — Yellowdig offers educators a gameful learning digital solution to improve student engagement by building learning communities.
  • ImpactableX — The social impact modeling & management toolkit behind leading solutions to our world's most pressing challenges.
  • GrowFlux — GrowFlux, Inc. they offers a ecosystem of commercial scale wireless lighting controls, cloud services, and cloud connected agricultural sensors.
Show more investments...

Oxford Bioscience Partners
VC Fund · Boston, Massachusetts, United States

Bigslot288 merupakan situs slot deposit pulsa 10 ribu tanpa potongan 2022, terbukti sebagai web slot pulsa tanpa potongan terpercaya jaminan taruhan 100% aman.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Series B, Series C, Series A
  • United States, Germany, Switzerland

Portfolio highlights

  • Paperspace — Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
  • CardioFocus — CardioFocus provides electrophysiologists with innovative and effective tools that bring precision and control to the treatment of atrial fibrillation.
  • Yolia Health — Yolia Health developed The True Vision Treatment or TVT, the 'Invisalign' for the eyes. A non-invasive treatment to correct vision problems like presbyopia without surgery. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses (TVT Contacts) and specially formulatedeye drops (TVT Eye Drops). After only 5 days of treatment with TVT patients are able to stop using the TVT Contacts, TVT Eye Drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia's treatment improves both near and distance vision, a unique feature no single other alternative can provide. ** Looking for sophisticated investors and key industry partners.
Show more investments...

U.S. Venture Partners
VC Fund · Menlo Park, California, United States · 10 investments in the past 12 months

U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Series B, Series C, Series A
  • United States, Israel, Canada

Portfolio highlights

  • Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
  • Trust Lab — Trust Lab develops solutions to detect and mitigate online safety threats and works with social media companies, advocacy groups, and other interested parties to implement them. Palo Alto, California, U.S.A.
  • Luminopia — Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One,to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.
Show more investments...

Khosla Ventures
VC Fund · Menlo Park, California, United States · 58 investments in the past 12 months

Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Headquartered in Menlo Park, Calif., Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech,digital health, medtech and diagnostics, therapeutics and frontier technology.

Show more...

Investment focus

  • Software, Health Care, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, India, United Kingdom

Portfolio highlights

  • CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
  • rabbit — Revolutionizing human-machine interaction
  • Vayu Robotics — Vayu Robotics is an AI robotics company that develops and commercializes automotive sensing, autonomous vehicles, and robotics technology.
Show more investments...

Catalyst Health Ventures
VC Fund · Braintree, Massachusetts, United States · 2 investments in the past 12 months

Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.

Show more...

Investment focus

  • Health Care, Medical Device, Medical
  • Series A, Series B, Series C
  • United States

Portfolio highlights

  • Rejoni — Rejoni uses bio-materials to develop medical devices that improve the outcome of minimally invasive and gynecological surgical procedures.
  • Instylla — Instylla delivers next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.
  • Avive Solutions — Check out Avive Solutions, the manufacturers of a brand new AED machine - portable defibrillator - that's FDA approved!
Show more investments...

Canaan Partners
VC Fund · Menlo Park, California, United States · 17 investments in the past 12 months

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, Israel, India

Portfolio highlights

  • Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
  • Actio Biosciences — At Actio, we are leveraging advances in genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare and common diseases. We are applying expertise in genetics, drug discovery, and data sciences to pinpoint targets that not only cause rare diseases with high unmet need, but that also hold promise in more common indications.
  • Diligent Robotics — We build robots like Moxi that assist hospital staff with routine activities so they can focus on caring for patients.
Show more investments...

Catalyst Health Ventures
VC Fund · Braintree, Massachusetts, United States

Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.

Show more...

Investment focus

  • Health Care, Medical Device, Medical
  • Series A, Series B, Series C
  • United States

Portfolio highlights

  • Epitel — Epilog is an unobtrusive wearable seizure detection system that records long-term EEG, anywhere. It gives people living with epilepsy peace of mind with a much-needed tool to better understand and manage their seizures.
  • Avive Solutions — Check out Avive Solutions, the manufacturers of a brand new AED machine - portable defibrillator - that's FDA approved!
  • PanTher Therapeutics — PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatmentat the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
Show more investments...

Sand Hill Angels
VC Fund · Mountain View, California, United States · 7 investments in the past 12 months

For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.

Show more...

Investment focus

  • Health Care, Software, Biotechnology
  • Seed, Series B, Series A
  • United States, Canada, Japan

Portfolio highlights

  • GaeaStar — The zero waste disposable clay cups. GaeaStar is an engineering company developing sustainable single use products and technology.
  • MOGL — MOGL is created for athletes by athletes. The platform empowers all athletes to seek out opportunities to monetize their name, image, and likeness in a safe...
  • PrivacyHawk — Privacyhawk is a mobile app that empowers everyone to take back control of their privacy.
Show more investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 7 investments in the past 12 months

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Switzerland, Canada

Portfolio highlights

  • Kate Therapeutics — Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
  • Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
  • Tentarix Biotherapeutics — Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Show more investments...

Tech Coast Angels
VC Fund · Newport Beach, California, United States · 3 investments in the past 12 months

Tech Coast Angels is the largest angel investor group in the United States, possessing more than 300 members in five networks in Los Angeles, Orange County, San Diego, Central Coast, and the Inland Empire. Its members provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.Members invest in companies in a wide range of industries, including the life sciences, biotech, IT, services, retail, Internet, financial, software, media, consumer products, and tech startups. TCA as a whole gives companies more than just capital; they also provide counsel, mentoring, and access to an extensive network of potential investors, customers, strategic partners, and management talent. Tech Coast Angels has been ranked by CB Insights to be among the Top 20 Angel Groups in the US; TCA was also ranked as #1 for Network Centrality, meaning we have more connections than anyone! If you are in the game-changing business, we are here to help.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed, Convertible Note, Funding Round
  • United States, Canada

Portfolio highlights

  • Reglagene — Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.
  • RealSeq Biosciences — RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
  • Trio Pharmaceuticals — TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company pioneering dual action drugs to generate immunogenic tumors. TRIO's innovative antibody drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways.
Show more investments...

Houston Angel Network
VC Fund · Houston, Texas, United States

The Houston Angel Network (HAN) is a nonprofit organization dedicated to developing the innovation ecosystem in Houston, Texas by supporting founders and startups with financial resources and mentorship.

Show more...

Investment focus

  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • United States, Canada, United Kingdom

Portfolio highlights

  • CaseCTRL — Schedule surgeries with ease using AI-powered surgical scheduling. Fewer canceled cases, conflicts, and misorders. More surgery and time for patients!
  • Materna Medical — Materna Medical empowers women to protect and restore their pelvic health.
  • Amplified Sciences — Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and providesa very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data.
Show more investments...

Morgenthaler Ventures
VC Fund · Menlo Park, California, United States · 2 investments in the past 12 months

Morgenthaler Ventures has been in the venture capital business for more than 45 years, steadily investing through every market cycle. Select past and present portfolio companies in the IT space include: Evernote, Lending Club, Siri, MuleSoft, Practice Fusion, Adara Media, Check, Doximity, PeopleMatter, Socrata, NuoDB, Jaspersoft, VoltageSecurity, Rhythm NewMedia, Nominum, Wize Commerce (NexTag) and back in the day, Apple.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Canada, France

Portfolio highlights

  • Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
  • SetPoint Medical — SetPoint Medical is pioneering bioelectronic medicine to develop a safe and cost-effective approach for treatment of chronic autoimmune diseases.
  • Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
Show more investments...

Radius Ventures
VC Fund · New York, New York, United States

Radius Ventures is a venture capital firm that invests in leading-edge, growth equity and expansion-stage health and life sciences companies. The firm is led by a seasoned group of investment professionals with collective experience across all major sectors of the industry, including medical devices, diagnostics, biopharmaceuticals, life sciencetools, healthcare services and healthcare information technology. Radius takes a hands-on approach with each portfolio company by providing intellectual capital, strategic guidance and access to key industry relationships that ultimately increase the odds of success.Founded in 1997, Radius Ventures is based in New York, United States.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Series B, Funding Round, Series C
  • United States

Portfolio highlights

  • Healthsense — Healthsense is a provider of remote monitoring technology solutions for the senior care continuum. With our full range of health and safety monitoring systems, providers are empowered to proactively deliver the highest quality care possible through critical health information. Caregivers reduce costs, increase independence and enhance seniorexperiences when armed with the right information at the right time.
  • EndoGastric Solutions — EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.
  • Minimally invasive devices — MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselvesto degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.
Show more investments...

Kleiner Perkins
VC Fund · Menlo Park, California, United States · 15 investments in the past 12 months

Kleiner Perkins is an American venture capital firm headquartered on Sand Hill Road in Menlo Park in Silicon Valley.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Series B, Series A, Series C
  • United States, China, United Kingdom

Portfolio highlights

  • Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Flagship — Flagship develops a SaaS data science solution that brings predictive machine-learning intelligence to retail. Its centralized platform helps businesses make timely, data-driven decisions across internal stakeholders and channels. Flagship enriches retail brands' first-party data with machine learning algorithms to optimize customer retention,inventory sell-through, and revenue.
  • Lightforce Orthodontics — LightForce Orthodontics, founded in 2015, makes the world’s first and only fully customized 3D-printed bracket system that is based on the anatomy and tooth morphology of each patient. The company’s mission is to apply modern technology and mass-customization to improve the orthodontic experience for both patients and doctors. LightForce’s platformunites the latest in digital treatment capabilities with cutting-edge, on-demand, 3D manufacturing to offer clinicians the first significant advancement in bracket-based treatment protocol in the past 50 years. A first-of-its-kind in the orthodontic space, Lightforce offers an unparalleled platform for orthodontists and LightForce technicians to collaborate on treatment plans for each individual patient. The company’s solution significantly reduces patient visits to the orthodontist and time spent wearing braces by providing 100 percent fully-customized solutions that improve both convenience and quality, ensuring patients receive the gold standard of care.
Show more investments...

Split Rock Partners
VC Fund · Minneapolis, Minnesota, United States

Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast. They are an early-stage venture capital firm that was founded in June 2004 by the former healthcare and software investment teams of St. Paul Venture Capital (SPVC). The Split Rock team managed over $1 billion of venturecapital during our tenure at SPVC, and continues to manage the SPVC healthcare and software portfolio. In May of 2008, they raised $300 million in the second Split Rock Partners fund, the successor to their inaugural $275 million fund raised in April 2005.The Split Rock team believes that it takes great people to translate promising ideas into compelling businesses. They are grounded in a fundamental respect for entrepreneurs and the rare combination of elements required when pioneering new markets. They start by looking for entrepreneurs with the passion, vision, and skills to build leading companies. They then work with entrepreneurs collaboratively, building partnerships based on integrity and mutual respect. The Split Rock team complements management expertise with over 80 years of venture investing and entrepreneurial management experience. They are proud of the strong relationships they have built with talented entrepreneurs and co-investors throughout their history and look forward to building on that tradition.

Show more...

Investment focus

  • Health Care, Medical Device, Medical
  • Series B, Series A, Series C
  • United States, France

Portfolio highlights

  • Gravia — More benefits. Fewer asterisks. We are a health benefits company on a mission to build a health plan that everyone can love.
  • EBR Systems — EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias.
  • Gravie — More benefits. Fewer asterisks. We are a health benefits company on a mission to build a health plan that everyone can love.
Show more investments...

Shangbay Capital
VC Fund · Palo Alto, California, United States · 11 investments in the past 12 months

ShangBay Capital is a venture capital company that brings best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early-stage venture equity participation

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Series A, Series B, Series D
  • United States, China, Canada

Portfolio highlights

  • Luminopia — Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One,to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.
  • Presidio Medical — Building Tomorrow's Neuromodulation Therapies. Presidio Medical is a clinical-stage, privately held medical technology company developing a transformational neuromodulation platform to treat diseases of undesired neural activity.
  • Laplace Interventional — Laplace developing Transcatheter Tricuspid Valve Technology to offer an increase in life expectancy and an improvement to the quality of life to worldwide patients with tricuspid regurgitation.
Show more investments...

DeNovo Ventures
VC Fund · Saratoga, California, United States · 1 investment in the past 12 months

DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would havesignificant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Series B, Series D, Series C
  • United States

Portfolio highlights

  • Avedro — Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases.
  • Milo — Milo is a group action communicator, sophisticated wireless networking, audio processing & powerful hardware in a carefully crafted design.
  • Spinal Kinetics — The artificial disc replacement device from Orthofix is changing the lives of people suffering from spinal pain. Learn about this motion-saving product.
Show more investments...

Third Rock Ventures
VC Fund · Boston, Massachusetts, United States · 5 investments in the past 12 months

Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States

Portfolio highlights

  • Flare Therapeutics — Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets fortranscription factor regulation to address mutations that cause disease. Our drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • CARGO Therapeutics — CARGO Therapeutics develops CAR T-cell therapy to overcome cancer treatment resistance and address access barriers so that more patients can benefit from potentially curative therapies. The company is on a mission to outwit cancer by developing best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite commercially available autologousCARs advancements, these treatments are curative for less than half of all cancer patients. Furthermore, far too many patients are unable to access these potentially curative therapies due to other obstacles such as manufacturing, supply constraints, long turnaround times, and reimbursement barriers. CARGO's team is intensely focused on pursuing novel solutions to improve cancer treatment outcomes and experiences.
Show more investments...

Gaingels
VC Fund · New York, New York, United States · 89 investments in the past 12 months

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Software, Health Care, FinTech
  • Seed, Series A, Series B
  • United States, Canada, Germany

Portfolio highlights

  • KittyCAD — Infrastructure for hardware design tools.
  • Paxton AI — Regulatory Intelligence, with the speed of Generative AI.
  • Atropos Health — Atropos Health rapidly provides personalized real-world evidence for any clinical decision
Show more investments...

St. Louis Arch Angels
VC Fund · St Louis, Missouri, United States · 1 investment in the past 12 months

The St. Louis Arch Angels is a network of accredited investors who fund early-stage businesses across the St. Louis region.

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Seed, Series A, Funding Round
  • United States, Argentina

Portfolio highlights

  • Peptyde Bio — Launched by the Danforth Technology Company, Peptyde Bio combines nature and artificial intelligence to develop nature-based biofungicides.
  • SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
  • Impetus Agriculture — Impetus Agriculture focuses on developing multiple topical or transgenic insect control products. Products that are safe, effective, and sustainable. Products that are not subject to the same insect resistance that has developed in current commercial products.
Show more investments...

Life Science Angels
VC Fund · Sunnyvale, California, United States · 1 investment in the past 12 months

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Funding Round, Seed, Series A
  • United States, Israel, The Netherlands

Portfolio highlights

  • InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
  • Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show more investments...

Three Arch Partners
VC Fund · Portola Valley, California, United States

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generatedstrong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series C, Series B, Funding Round
  • United States, Belgium

Portfolio highlights

  • Nevro — We Believe True Innovation Transforms More Lives
  • Neuronetics — Antidepressant medications don't work for everyone. If drugs haven't worked for you, learn about NeuroStar - safe, effective, lasting TMS therapy for depression.
  • Access Closure — Access Closure, Inc., a medical device company, provides access site management products to address the complex challenge of vascular closure during interventional and diagnostic procedures. The company's products include Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble and extravascular sealant,which expands in the tissue tract by absorbing blood and subcutaneous fluids. Access Closure, Inc. was founded in 2002 and is based in Mountain View, California.
Show more investments...

Virginia Venture Partners
VC Fund · Herndon, Virginia, United States · 23 investments in the past 12 months

Virginia Venture Partners is a family of seed- and early-stage investment funds placing near-equity and equity investments in Virginia-based technology, life science, and cleantech companies. Virginia Venture Partners invests in companies with a high potential for achieving rapid growth and generating significant economic return for entrepreneurs,co-investors and the Commonwealth of Virginia. CIT’s family of funds includes:GAP Fund I – A vintage 2004 fund fully invested in a broad array of seed-stage technology companies. Portfolio.GAP BioLife Fund – A seed fund investing exclusively in life science companies. GAP Tech Fund – A seed fund investing in IT and technology companies.Commonwealth Energy Fund (CEF), a seed fund investing in energy efficiency and renewable energy companies.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Seed, Funding Round, Series A
  • United States, Canada, France

Portfolio highlights

  • WRANGLD — WRANGLD operates as a SaaS company that provides a platform for the trades and service industries.
  • OpsCanvas — Traditional deployments often involve writing hundreds of lines of complex IaC code, which can be time-consuming and prone to errors. OpsCanvas changes the game by offering Draw and Deploy deployments using generative IaC, which automates the production of configuration file code and abstracts the difficult and necessary tasks required in the deployment process.
  • Liquet Medical — Liquet Medical is a medical device development company that transforms the way the vascular disease is treated through localized drug delivery. The Versus Catheter will be Liquet Medical’s first technology to market.
Show more investments...

Silicon Valley Bank
VC Fund · Santa Clara, California, United States · 38 investments in the past 12 months

Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Debt Financing, Series B, Series A
  • United States, United Kingdom, Canada

Portfolio highlights

  • SafeRide Health — SafeRide Health provides technology-forward non-emergency medical transportation (NEMT) services for care providers and health plans offering Medicare Advantage and Medicaid. We intelligently improve and simplify NEMT to improve health outcomes and healthcare satisfaction.
  • Rainforest — Rainforest focuses on providing software platforms for payment processing. Rainforest is headquartered in Atlanta, United States.
  • Olema Oncology — At Olema Oncology, we leverage our deep understanding of endocrine-driven cancers, nuclear receptors and mechanisms of acquired resistance with the goal of transforming the standard of care for women living with cancer by focusing on developing more convenient and effective therapies. Join us as we aim to design therapies for improving lives.
Show more investments...

Mayo Clinic
VC Fund · Rochester, Minnesota, United States · 10 investments in the past 12 months

Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • United States, Israel, China

Portfolio highlights

  • MEDIVIS — Medivis is a leader in AR for healthcare, using augmented reality and artificial intelligence to advance medical imaging and surgical precision.
  • The Contract Network — AI-powered collaborative contracting is an innovative approach to contract negotiation that emphasizes real-time collaboration, communication, and transparency.
  • Collaborative Robotics — Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction.
Show more investments...

Monte Carlo Capital
VC Fund · Monaco, Bayern, Germany · 2 investments in the past 12 months

Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).

Show more...

Investment focus

  • Medical Device, Artificial Intelligence, Medical
  • Seed, Funding Round, Series A
  • United States, United Kingdom, Spain

Portfolio highlights

  • HomeOptions — Home ownership redefined - We pay homeowners to be their future real estate broker.
  • Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
  • Immersive Fox — Immersive Fox develops a text-to-video B2B service to generate video content for companies remotely. It also creates AI-generated microlearning videos from any text for learning management systems and corporate communication.
Show more investments...

Hatteras Venture Partners
VC Fund · Durham, North Carolina, United States · 4 investments in the past 12 months

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Funding Round
  • United States, Canada

Portfolio highlights

  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
  • Aer Therapeutics — Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.
  • Mercy BioAnalytics — We are making early stage cancer 100,000x easier to find using extracellular vesicles found in blood, specific to their parent cells.
Show more investments...

Boutique Venture Partners
VC Fund · Palo Alto, California, United States · 3 investments in the past 12 months

Boutique Venture Partners specializes in early-stage investments in healthcare and life sciences

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States, Canada, France

Portfolio highlights

  • Surge — PreCyte integrates high-resolution immune system exploration with predictive information to develop preventive strategies, treatments, medical devices.
  • Zeda — Where ideas become reality Zeda's objective is to better lives by investing in cutting-edge technologies, innovative companies, and groundbreaking ideas. Leveraging Advanced Manufacturing Helping companies solve some of their most difficult challenges Series B Announcement Zeda, Inc. (previously PrinterPrezz / Vertex Manufacturing), a global leader in advanced 3D manufacturing and nanotech solutions for the medical,
  • Smartlens — Smartlens, Inc. is a medical technology company making non-invasive soft contact lenses as a convenient and affordable way of diurnal IOP (eye pressure) measurement. Smartlens helps with screening, diagnosis, and treatment of Glaucoma - the leading cause of irreversible blindness.
Show more investments...

Golden Seeds
VC Fund · New York, New York, United States · 6 investments in the past 12 months

Golden Seeds is a seed-stage investment firm with a focus on women leaders. Their investment thesis rests on the extensive research that concludes that gender-diverse teams produce a better return on equity. By seeking companies where women hold leadership positions and own substantial equity, they are funding companies that are likely to havediverse perspectives that will contribute to success.

Show more...

Investment focus

  • Health Care, Software, Biotechnology
  • Series A, Seed, Series B
  • United States, Canada

Portfolio highlights

  • Nalu Bio — Nalu Bio is the leading innovator in the discovery and production of next generation cannabinoid ingredients.
  • EliseAI — Elise is an artificially intelligent leasing agent for multifamily communities. As an AI leasing assistant, Elise responds, follows up, and books showing appointments.
  • Jurata Thin Film — Revolutionizing the manufacturing, storage, and delivery of vaccines and biologics
Show more investments...

Cherrystone Angel Group
VC Fund · Providence, Rhode Island, United States

Cherrystone Angel Group, founded in 2004 and comprised of over 60 Rhode Island members, is Rhode Island’s first organized angel investment group. Its members invest in early stage, typically pre-revenue companies, across the tri-state region. While it is the entrepreneur who drives the company — and on whom ultimate success depends —Cherrystone believes that good advice and focused expertise are vital to the success of any business venture. When Cherrystone invests, it not only brings money to the table but industry knowledge and connections that will make its business succeed. All its members are experienced and qualified investors who have either built their own companies or have extensive experience launching new business ventures. Their backgrounds include creating or working with manufacturing, distribution, technology, and service companies.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical Device
  • Series A, Series B, Seed
  • United States

Portfolio highlights

  • Jaia Robotics — Aquatic data collection is our passion using micro sized low cost hybrid autonomous surface vehicles and underwater vehicles.
  • Lenoss Medical — Lenoss Medical engages in providing solutions that support the natural osseous healing process. They disrupt the treatment of spinal fractures with the osteopearl VBA system, a viable, minimally invasive, and cement-free technology that utilizes the natural healing properties of healthy bone.
  • Advanced Silicon Group — Advanced Silicon Group operates a nanotechnology company dedicated to commercializing silicon nanotechnology. The company was founded in 2015 with the goal of commercializing silicon nanotechnology developed by ASG employees.
Show more investments...

New Enterprise Associates
VC Fund · Menlo Park, California, United States · 47 investments in the past 12 months

New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from the seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, China

Portfolio highlights

  • Meeno — Meeno is a relationship mentoring app powered by generative AI
  • Rocket.Chat — Explore Rocket.Chat, where we put data privacy into every conversation and enable teams to collaborate seamlessly.
  • Pulumi — Pulumi's open source infrastructure as code SDK enables you to create, deploy, and manage infrastructure on any cloud, using your favorite languages.
Show more investments...

Green Park & Golf Ventures
VC Fund · Dallas, Texas, United States · 2 investments in the past 12 months

Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, Sweden

Portfolio highlights

  • Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
Show more investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in United States by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck